DE1793465C3 - - Google Patents

Info

Publication number
DE1793465C3
DE1793465C3 DE19681793465 DE1793465A DE1793465C3 DE 1793465 C3 DE1793465 C3 DE 1793465C3 DE 19681793465 DE19681793465 DE 19681793465 DE 1793465 A DE1793465 A DE 1793465A DE 1793465 C3 DE1793465 C3 DE 1793465C3
Authority
DE
Germany
Prior art keywords
heptaminol
cinnamate
dose
hydrochloride
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19681793465
Other languages
German (de)
English (en)
Other versions
DE1793465A1 (de
Inventor
Yves La Celle Saint-Cloud Yvelines Huet
Carlos Paris Pomaret
Bernard Meudon Hauts-Deseine Pourrias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Priority to DE19681793465 priority Critical patent/DE1793465A1/de
Publication of DE1793465A1 publication Critical patent/DE1793465A1/de
Application granted granted Critical
Publication of DE1793465C3 publication Critical patent/DE1793465C3/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • E—FIXED CONSTRUCTIONS
    • E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
    • E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
    • E06B9/00—Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
    • E06B9/02—Shutters, movable grilles, or other safety closing devices, e.g. against burglary
    • E06B9/08—Roll-type closures
    • E06B9/11—Roller shutters
    • E06B9/15—Roller shutters with closing members formed of slats or the like
    • E06B9/165—Roller shutters with closing members formed of slats or the like with slats disappearing in each other; with slats the distance between which can be altered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Structural Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Civil Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Architecture (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19681793465 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung Granted DE1793465A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19681793465 DE1793465A1 (de) 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681793465 DE1793465A1 (de) 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung

Publications (2)

Publication Number Publication Date
DE1793465A1 DE1793465A1 (de) 1971-07-22
DE1793465C3 true DE1793465C3 (enExample) 1973-01-04

Family

ID=5707715

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681793465 Granted DE1793465A1 (de) 1968-09-20 1968-09-20 Neues Salz des Heptaminols und Verfahren zu seiner Herstellung

Country Status (1)

Country Link
DE (1) DE1793465A1 (enExample)

Also Published As

Publication number Publication date
DE1793465A1 (de) 1971-07-22

Similar Documents

Publication Publication Date Title
DE2904445C2 (de) N↓1↓-(4-Amino-6.7-dimethoxy-2-chinazolyl)-N↓1↓-methyl-N↓2↓-(2-tetrahydrofuroyl)-1.3-propandiamin, seine Herstellung und seine pharmazeutische Verwendung
DE2310918C3 (de) 3-Isobutoxy-2-pyrrolidino-N-phenyl-N-benzylpropylamin, dessen Salze Verfahren zu deren Herstellung und Arzneimittel
EP0800827A1 (de) Regelung der Reaktivität von humanen Blutplättchen durch Verabreichung eines Extrakts der Strandkiefer (Pycnogenol TM)
DE69736130T2 (de) Pharmazeutische produkte zur heilung und vorbeugung von krankheiten, die aus der beschädigung der vaskulären endothelzellen hervorgehen
DE2403122C2 (enExample)
EP0166183B1 (de) Verwendung von Hydroxyindolderivaten zur Herstellung eines Arzneimittels zur Senkung des Blutdrucks
DE1670005C2 (de) β-(4,5-Diphenyloxazol-2-yl)-propionsäure oder ein pharmazeutisch verträgliches Salz davon, Verfahren zur Herstellung dieser Verbindungen und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE2951671C2 (de) Arzneimittelzubereitung mit Antithrombosewirkung und Hemmwirkung auf die Agglomeration der Blutplättchen
CH661208A5 (de) Arzneimittelpraeparat mit antiarrhythmischer wirkung.
Khamroev et al. Study Of The General Pharmacological Properties Of A New Antiarrhythmic N-Deacetyllappaconitine With Oral Administration
DE2224130C3 (de) Tryptophanderivate und sie enthaltende pharmazeutische Zubereitungen
DE3205149C2 (enExample)
DE2131679A1 (de) 3,4,5-Trimethoxybenzamidocarbonsaeure und ihre Salze sowie Arzneipraeparate
DE2333831C3 (de) l-(2-Benzoyl-äthyl)-2-(4-a- cinnamylpiperazinomethyQ-benzimidazole, Verfahren zur ihrer Herstellung und ihre therapeutische Verwendung
DE1793465B (de) Salz der Zimtsaure mit 6 Ammo 2 methyl 2 heptanol
DE2062055C3 (de) Propanolamin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3419067C2 (enExample)
DE2038628B2 (de) N,N'-Di(carboxyalkyl)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2113489C3 (de) 2-Nitro-benzofuranderivate, ein Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE1470012B2 (de) Papaverinsalz der 7-theophyllin-n- propan-omega-sulfonsaeure
DE2521905C2 (de) Arzneimittel zur cerebralen Durchblutungsförderung
DE2145359A1 (de) Neue Phthalazindenvate
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
CH650673A5 (de) Ein trithiazolpentamethincyaninderivat enthaltendes pharmazeutisches mittel.
DE1915795C3 (de) N- (3,4,5-Trimethoxycinnamoyl) -N'- (carbonylmethyl) -piperazinderivate und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee